GW Pharmaceuticals plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
91.14 | 57.09 | 59.63% | -126.95 | -171.79% |
| P/S |
|
12.3 | 33.5 | -63.28% |
|
|
| P/BV |
|
9.4 | 4.61 | 103.72% |
|
|
| P/FCF |
|
-149.35 | 39.66 | -476.56% |
|
|
| Ev/Ebitda |
|
-163.78 | -19.46 | 741.81% |
|
|
| Ev/S |
|
11.43 | 22.56 | -49.33% |
|
|
| Ev/FCF |
|
-138.91 | 45.47 | -405.5% |
|
|
| E/P |
|
-0.0102 | 0.0172 | -159.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6.98 | -14.58 | -52.16% | -710.09 | -99.02% |
| ROE |
|
-9.62 | 9.48 | -201.45% |
|
|
| ROA |
|
-7.81 | 0.1068 | -7412.91% |
|
|
| ROIC |
|
-9.05 | 7.63 | -218.54% |
|
|
| ROS |
|
-12.52 | -26.35 | -52.49% |
|
|
| ROCE |
|
0 | 13.75 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.12 | -3.73 | -70.02% | -0.734 | +52.3% |
| Nеt Debt/Ebitda |
|
0 | -3.19 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1777 | -100% |
|
|
| Debt/Equity |
|
0 | 1.57 | -100% |
|
|
| Debt/Net Income |
|
-0.6229 | 0.8429 | -173.89% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.69 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
3953.85 | 73.67 | 5266.97% | ||
| Growth impulse Ebitda in 5 years |
|
-79.57 | 15.28 | -620.75% | ||
| Growth impulse Net Income in 5 years |
|
-30.12 | -33.08 | -8.95% | ||
| Growth impulse FCF in 5 years |
|
-54.92 | -8.35 | 557.72% | ||
| Growth impulse EPS in 5 years |
|
-99.26 | -64.95 | 52.83% |
IP Score
2.75/10
